Skip to content


Digitoxin is a small molecule pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against sodium/potassium-transporting ATPase subunit alpha-1.
Trade Name
Common Name Digitoxin
Indication anxiety disorders, atrial fibrillation, atrial flutter, cardiogenic shock, heart failure, low cardiac output, supraventricular tachycardia
Drug Class Fluoroquinolone derivatives, nonantibacterial indications (e.g., antineoplastic antibiotics)
Get full access now